In a dramatic demonstration of the power of evolutionary thinking for cancer research, adaptive therapy has been shown to be substantially superior to regular treatment for metastatic prostate cancer. Only 1 of 11 patients in the adaptive therapy cohort showed radiographic disease progression, compared to 14 of 16 in the usual treatment condition. The adaptive therapy group got cumulative drug doses less than half that of the usual group.
Zhang, J., Cunningham, J. J., Brown, J. S., & Gatenby, R. A. (2017). Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nature Communications 8, Article number: 1816 (2017) doi:10.1038/s41467-017-01968-5
ABSTRACT: Abiraterone treats metastatic castrate-resistant prostate cancer by inhibiting CYP17A, an enzyme for testosterone auto-production. With standard dosing, evolution of resistance with treatment failure (radiographic progression) occurs at a median of ~16.5 months. We hypothesize time to progression (TTP) could be increased by integrating evolutionary dynamics into therapy. We developed an evolutionary game theory model using Lotka–Volterra equations with three competing cancer “species”: androgen dependent, androgen producing, and androgen independent. Simulations with standard abiraterone dosing demonstrate strong selection for androgen-independent cells and rapid treatment failure. Adaptive therapy, using patient-specific tumor dynamics to inform on/off treatment cycles, suppresses proliferation of androgen-independent cells and lowers cumulative drug dose. In a pilot clinical trial, 10 of 11 patients maintained stable oscillations of tumor burdens; median TTP is at least 27 months with reduced cumulative drug use of 47% of standard dosing. The outcomes show significant improvement over published studies and a contemporaneous population.
Resistance, to antibiotics and insecticides, is one of the world's biggest medical and public health problems. In a new open access article in Evolutionary Applications, Silvie Huijben and Krijn Paaaijams argue that it is time to put sophisticated evolutionary theory to work to solve the problem.
Huijben, S., & Paaijmans, K. P. (n.d.). Putting evolution in elimination: Winning our ongoing battle with evolving malaria mosquitoes and parasites.
Abstract: Since 2000, the world has made significant progress in reducing malaria morbidity and mortality, and several countries in Africa, South America and South-East Asia are working hard to eliminate the disease. These elimination efforts continue to rely heavily on antimalarial drugs and insecticide-based interventions, which remain the cornerstones of malaria treatment and prevention. However, resistance has emerged against nearly every antimalarial drug and insecticide that is available. In this review we discuss the evolutionary consequences of the way we currently implement antimalarial interventions, which is leading to resistance and may ultimately lead to control failure, but also how evolutionary principles can be applied to extend the lifespan of current and novel interventions. A greater understanding of the general evolutionary principles that are at the core of emerging resistance is urgently needed if we are to develop improved resistance management strategies with the ultimate goal to achieve a malaria-free world. read more
Evolutionary Applications, n/a-n/a. https://doi.org/10.1111/eva.12530
Evolutionary Applications has a lovely series of articles on Evolutionary Toxicology, now available open access. Highly recommended!
Evolutionary responses to crude oil from the Deepwater Horizon oil spill by the copepod Eurytemora affinis (pages 813–828)Carol Eunmi Lee, Jane Louise Remfert, Taylor Opgenorth, Kristin M. Lee, Elizabeth Stanford, Joseph William Connolly, Jinwoo Kim and Sarah Tomke
- Evolutionary toxicology: Toward a unified understanding of life's response to toxic chemicals (pages 745–751)Steven P. Brady, Emily Monosson, Cole W. Matson and John W. Bickham
Version of Record online: 10 NOV 2017 | DOI: 10.1111/eva.12519
- Evolutionary toxicology in an omics world (pages 752–761)Elias M. Oziolor, John W. Bickham and Cole W. Matson
Version of Record online: 20 FEB 2017 | DOI: 10.1111/eva.12462
- Elevated mitochondrial genome variation after 50 generations of radiation exposure in a wild rodent (pages 784–791)Robert J. Baker, Benjamin Dickins, Jeffrey K. Wickliffe, Faisal A. A. Khan, Sergey Gaschak, Kateryna D. Makova and Caleb D. Phillips
Version of Record online: 22 JUN 2017 | DOI: 10.1111/eva.12475
- You have full text access to this OnlineOpen articleEvolved pesticide tolerance influences susceptibility to parasites in amphibians(pages 802–812)Jessica Hua, Vanessa P. Wuerthner, Devin K. Jones, Brian Mattes, Rickey D. Cothran, Rick A. Relyea and Jason T. Hoverman
Version of Record online: 4 JUL 2017 | DOI: 10.1111/eva.12500
- You have full text access to this OnlineOpen articleIncorporating evolutionary insights to improve ecotoxicology for freshwater species (pages 829–838)Steven P. Brady, Jonathan L. Richardson and Bethany K. Kunz
Version of Record online: 10 NOV 2017 | DOI: 10.1111/eva.12507
- Adaptation costs to constant and alternating polluted environments (pages 839–851)Morgan Dutilleul, Denis Réale, Benoit Goussen, Catherine Lecomte, Simon Galas and Jean-Marc Bonzom
Version of Record online: 10 NOV 2017 | DOI: 10.1111/eva.12510
Version of Record online: 16 AUG 2017 | DOI: 10.1111/eva.12502
Genetic and epigenetic variation in Spartina alterniflora following the Deepwater Horizon oil spill (pages 792–801)Marta Robertson, Aaron Schrey, Ashley Shayter, Christina J Moss and Christina Richards
Version of Record online: 12 MAY 2017 | DOI: 10.1111/eva.12482
It has long been recognized (at least in evolutionarily informed circles) that the immune system faces a dire tradeoff: too little or too specific a immune response and pathogens triumph, too much or too nonspecific and the system attacks host tissues. A new paper in Nature Ecology and Evolution analyzes the problem systematically using tools from signal detection theory. This is likely to become a landmark paper. Alas, it is not open access, but the abstract is below.
Metcalf, C. J. E., Tate, A. T., & Graham, A. L. (2017). Demographically framing trade-offs between sensitivity and specificity illuminates selection on immunity. Nature Ecology & Evolution, 1(11), 1766–1772. https://doi.org/10.1038/s41559-017-0315-3
Abstract: A fundamental challenge faced by the immune system is to discriminate contexts meriting activation from contexts in which activation would be harmful. Selection pressures on this ability are likely to be acute: the penalty of mis-identification of pathogens (therefore failure to attack them) is mortality or morbidity linked to infectious disease, which could reduce fitness by reducing lifespan or fertility; the penalty associated with mis-identification of host (therefore self-attack) is immunopathology, whose fitness costs can also be extreme. Here we use classic epidemiological tools to frame this trade-off between sensitivity and specificity of immune activation, exploring implications for evolution of immune discrimination. We capture the expected increase in the evolutionarily optimal sensitivity under higher pathogen mortality risk, and a decrease in sensitivity with increased immunopathology mortality risk; but a number of non-intuitive predictions also emerge. All else being equal, optimal sensitivity decreases with increasing lifespan; and, where sensitivity can vary over age, decreases at late ages not solely attributable to immunosenescence are predicted. These results both enrich and challenge previous predictions concerning the relationship between life expectancy and optimal evolved defenses, highlighting the need to account for epidemiological setting, lifestage-specific immune priorities, and immune discrimination in future investigations.